National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 19919 [2014-07971]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 69 / Thursday, April 10, 2014 / Notices
sroberts on DSK5SPTVN1PROD with NOTICES
the experts emphasized the critical
importance of environmental
complexity rather than focusing only on
the square footage of living space per
chimpanzee as a means of ensuring
species-typical behavior. The experts
also noted that different animals/groups
within a colony would require different
stimuli to exhibit species-typical
behavior. The experts reiterated the
difficulty in identifying square footage
requirements, including lack of
published literature in this area. Based
on their experience in behavioral
management of chimpanzees, as
veterinarians and by directing and
operating facilities for captive research
chimpanzees, several of the experts
recommended minimum space needed
to promote species-typical behavior.
The recommendations ranged from 150–
500 ft2 of living space per animal.
https://dpcpsi.nih.gov/sites/default/files/
NIH_response_to_Council_of_Councils_
recommendations_62513.pdf). The NIH
expects the facilities it supports to
monitor the chimpanzees for speciestypical behavior.
The NIH has prepared procedural
guidance and technical assistance for
researchers, facility staff, and agency
staff to ensure proper implementation of
the agency’s decisions. Investigators
should follow guidance (see NOT–OD–
14–024 at https://www.grants.nih.gov/
grants/guide/notice-files/NOT-OD-14024.html) regarding the submission of
applications, proposals, or protocols for
research involving chimpanzees.
Conclusion
The literature review demonstrated
there is little published literature
containing quantitative scientific data
that can be used to support a
determination of the minimum space
density (horizontal surface area per
animal) needed to support an EAE for
captive chimpanzees. Furthermore,
other aspects of enclosure design, such
as complexity and vertical height, are
considered by many experts to be more
important than space density with
respect to chimpanzee well-being and
the promotion of species-specific
behavior.
Based on both the literature review
and recommendations from individual
experts, it is clear that published
guidelines for minimum living space
area for captive research chimpanzees
are variable. Encouraging speciestypical behavior among chimpanzees
does not simply result from providing a
minimum square footage of living space
per animal. Rather, the characteristics
(complexity) of the space as well as
enrichment opportunities have a
significant effect on promoting speciestypical behavior. The environment
should take into account the individual
chimpanzees’ and colony
characteristics, including social, health,
age, and biological factors.
Based on the recommendation from
the Council of Councils, the information
contained in the literature review, and
additional input from scientific,
veterinary, and facility experts, the NIH
has decided that the density of the
primary living space of chimpanzees
should be at least 250 ft2 per
chimpanzee. This decision supplements
the agency decisions on the nine EAE
recommendations made by the Council
of Councils (see EA1, EA3–10 at
VerDate Mar<15>2010
18:14 Apr 09, 2014
Jkt 232001
19919
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS).
Dated: February 25, 2014.
Francis S. Collins,
Director, National Institutes of Health.
Dated: April 4, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–08062 Filed 4–9–14; 8:45 am]
[FR Doc. 2014–07971 Filed 4–9–14; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
National Center for Complementary &
Alternative Medicine; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NHLBI.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Heart, Lung, and Blood
Institute, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NHLBI.
Date: May 5–7, 2014.
Time: 6:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Robert S Balaban, Ph.D.,
Scientific Director, Division of Intramural
Research, NHLBI, National Institutes of
Health, Building 10, CRC, 4th Fl., Room 4–
1581, 10 Center Drive, Bethesda, MD 20892,
301–496–2116.
Any interested person may file written
comments with the committee by forwarding
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council for
Complementary and Alternative
Medicine.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Alternative
Medicine NCCAM Advisory Council Board.
Date: June 6, 2014.
Closed: 8:30 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\10APN1.SGM
10APN1
]]>Agencies
[Federal Register Volume 79, Number 69 (Thursday, April 10, 2014)]
[Notices]
[Page 19919]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-07971]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, NHLBI.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Heart, Lung, and Blood Institute, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NHLBI.
Date: May 5-7, 2014.
Time: 6:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Robert S Balaban, Ph.D., Scientific Director,
Division of Intramural Research, NHLBI, National Institutes of
Health, Building 10, CRC, 4th Fl., Room 4-1581, 10 Center Drive,
Bethesda, MD 20892, 301-496-2116.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS).
Dated: April 4, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-07971 Filed 4-9-14; 8:45 am]
BILLING CODE 4140-01-P
